Company intelligence / Profile preview
Shenzhen Forward Pharmaceutical Co., Ltd.
Shenzhen, Guangdong, Chinaforward-pharm.com ↗
- Ownership
- Private
- Development stage
- Phase 1
01
Overview
Shenzhen Forward Pharmaceutical is a private Chinese biotech company focused on innovative oncology and autoimmune disease therapies. Its two leading assets are FWD1509, a next-generation EGFR/HER2 TKI for NSCLC with brain metastasis potential currently in Phase I/II trials in China and the US, and FWD1802, an oral third-generation SERD for ER+ breast cancer cleared for Phase I by both FDA and NMPA. The company also has preclinical programs targeting FGFR2, KRAS G12C/G12D mutations, and an IL13-specific mAb for severe asthma/atopic dermatitis. Early clinical data show promising efficacy signals with good safety profiles.
- Therapeutic areas
- OncologyImmunology
- Modalities
- Small molecule drugsMonoclonal antibodies (mAbs)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Shenzhen Nanshan SEI InvestmentQihang CapitalLeaguer FundYunkun Fundfinancial adviser China Supernova Capital
Beyond the preview
Go deeper on Shenzhen Forward Pharmaceutical Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shenzhen Forward Pharmaceutical Co., Ltd..